Elite Primary Care DBA Elite Methadone Clinic

Elite Primary Care DBA Elite Methadone Clinic, based in Las Cruces, NM, is one of the SAMHSA-registered treatment programs operating in NM. The facility's programming is outpatient (Outpatient, MAT), not residential. What this page can help with is the frame — what to ask, what to verify, what to compare against.

Care levels at Elite Primary Care DBA Elite Methadone Clinic

On care levels specifically: Elite Primary Care DBA Elite Methadone Clinic is an outpatient-focused program (Outpatient, MAT) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. What that means in practice is that matching Elite Primary Care DBA Elite Methadone Clinic to the right clinical situation depends on whether you or a loved one needs the level of care this facility actually offers — which is a clinician's judgment, not a facility's sales pitch.

Insurance and payment

Elite Primary Care DBA Elite Methadone Clinic accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The facility also accepts TRICARE or military benefits. The single most useful pre-admission move on insurance is requesting the facility send you — in writing, by email — the specific benefits verification for your specific plan product. That document is the answer to most post-admission billing disputes.

Specialty programming

The facility's documented specialty programming includes: Adult women, Pregnant/postpartum women, Adult men. The specialty question rewards specific follow-up: what clinicians provide the specialty content, what their credentials are, what percentage of weekly programming is specialty-specific vs. general programming.

Before you call

Before admission to Elite Primary Care DBA Elite Methadone Clinic, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.